Author:
Leusen Jeanette H. W.,Nimmerjahn Falk
Reference83 articles.
1. Aalberse RC, van der Gaag R, van Leeuwen J (1983) Serologic aspects of IgG4 antibodies. I. Prolonged immunization results in an IgG4-restricted response. J Immunol 130(2):722–726, PubMed PMID: 6600252
2. Baerenwaldt A, Lux A, Danzer H, Spriewald BM, Ullrich E, Heidkamp G et al (2011) Fcgamma receptor IIB (FcgammaRIIB) maintains humoral tolerance in the human immune system in vivo. Proc Natl Acad Sci USA 108(46):18772–18777, PubMed PMID: 22065769. Pubmed Central PMCID: 3219118
3. Barnes N, Gavin AL, Tan PS, Mottram P, Koentgen F, Hogarth PM (2002) FcgammaRI-deficient mice show multiple alterations to inflammatory and immune responses. Immunity 16(3):379–389, PubMed PMID: 11911823
4. Baudino L, Nimmerjahn F, Azeredo da Silveira S, Martinez-Soria E, Saito T, Carroll M et al (2008) Differential contribution of three activating IgG Fc receptors (FcgammaRI, FcgammaRIII, and FcgammaRIV) to IgG2a- and IgG2b-induced autoimmune hemolytic anemia in mice. J Immunol 180(3):1948–1953, PubMed PMID: 18209093
5. Bevaart L, Jansen MJ, van Vugt MJ, Verbeek JS, van de Winkel JG, Leusen JH (2006) The high-affinity IgG receptor, FcgammaRI, plays a central role in antibody therapy of experimental melanoma. Cancer Res 66(3):1261–1264, PubMed PMID: 16452176
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献